NCT00005046View on ClinicalTrials.gov

Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 2000

Primary Completion Date

January 31, 2007

Conditions
Ovarian CancerPrimary Peritoneal Cavity Cancer
Interventions
DRUG

chemotherapy

DRUG

paclitaxel

Trial Locations (5)

44195

Cleveland Clinic Taussig Cancer Center, Cleveland

63110

Washington University School of Medicine, St Louis

92868

Chao Family Comprehensive Cancer Center, Orange

60637-1470

University of Chicago Cancer Research Center, Chicago

46202-5289

Indiana University Cancer Center, Indianapolis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00005046 - Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal Cancer | Biotech Hunter | Biotech Hunter